News

May 9, 2018

Siamab’s ST1 Therapy Candidate Promising Against Chemoresistant Ovarian Cancer, Study Shows

News

Siamab Therapeutics‘ investigational antibody-drug conjugate ST1 has promising anti-tumor effects against chemotherapy-resistant ovarian cancer in cell and animal models, a study shows. The study, “Treatment of ovarian cancer by targeting the tumor stem cell-associated ... Read more

May 7, 2018

Phase 3 Trial of Mirvetuximab Soravtansine in Ovarian Cancer OK’d to Continue as Planned

News

A Phase 3 trial evaluating ImmunoGen’s mirvetuximab soravtansine (IMGN853) in platinum-resistant ovarian cancer patients is on its way to achieving its objectives, an interim futility analysis shows. As a result, the FORWARD ... Read more

May 4, 2018

Do Your Part to Support World Ovarian Cancer Day on May 8

News

May 8 is World Ovarian Cancer Day (WOCD) an initiative of the World Ovarian Cancer Coalition that brings together women living with ovarian cancer, their families, and supporters to raise awareness about this ... Read more

May 2, 2018May 2, 2018

Phase 2 Study May Be Added to Ongoing Trial of Combo Ovarian Cancer Immunotherapy

News

Immunovaccine and Incyte Corporation are expanding their collaboration on a clinical trial, and plan to add a Phase 2 to their ongoing Phase 1b study in advanced ovarian cancer. The ... Read more

April 30, 2018

Zejula Shows Ability to Treat Range of Advanced Ovarian Cancers in Phase 2 Trial

News

Zejula (niraparib) showed an ability to treat people with recurrent and heavily treated ovarian cancer, particularly those with mutations in DNA repairing genes, results of a Phase 2 trial show. Tesaro’s ... Read more

April 27, 2018

IONTAS and IGEM Collaborate to Find Novel IgE Antibodies for Cancer Treatment

News

The development of novel IgE antibodies targeting solid tumors will receive a boost following a new collaboration between IONTAS and IGEM Therapeutics. IGEM is an immuno-oncology company developing novel immunoglobulin E (IgE) ... Read more

April 23, 2018

New Sensor Detects Ovarian Cancer in Noninvasive Manner in Mice, Study Shows

News

A new sensor, found capable of identifying ovarian cancer in a noninvasive way in mice, may have the potential to detect early-stage ovarian cancer in the future, and possibly monitor for ... Read more

April 20, 2018April 20, 2018

Rivkin Center Awards $1.18 Million in Ovarian Cancer Research Grants

News

The nonprofit Rivkin Center for Ovarian Cancer recently awarded $1.185 million in research grants for 2018 – a 10 percent increase from 2017 – to fund projects that will study ... Read more

April 18, 2018

Personalized Vaccine for Advanced Ovarian Cancer Offers Promising Results in Pilot Study

News

A personalized vaccine targeted to a patient’s own tumor cells yielded promising results in patients with recurrent advanced ovarian cancer, a Phase 1 pilot trial shows. The vaccine was safe, ... Read more

April 16, 2018

Approved Blood Cancer Inhibitors May Be Effective Therapy for Ovarian Tumors, Study Finds

News

A class of inhibitors approved for the treatment of several blood cancers may be an effective therapy for ovarian cancer patients who have mutations in the ARID1A gene, according to researchers. ... Read more